V, M., RK, D., L, B., R, M., NSS, K., A, S., . . . R, B. (2023). Safety and tolerability of long-term apomorphine infusion in advanced Parkinson's disease: An Indian multi-center (APO-IND) experience. Scientific reports, 13(1), 18681. https://doi.org/10.1038/s41598-023-46003-4
Chicago Style (17th ed.) CitationV, Metta, et al. "Safety and Tolerability of Long-term Apomorphine Infusion in Advanced Parkinson's Disease: An Indian Multi-center (APO-IND) Experience." Scientific Reports 13, no. 1 (2023): 18681. https://doi.org/10.1038/s41598-023-46003-4.
MLA (9th ed.) CitationV, Metta, et al. "Safety and Tolerability of Long-term Apomorphine Infusion in Advanced Parkinson's Disease: An Indian Multi-center (APO-IND) Experience." Scientific Reports, vol. 13, no. 1, 2023, p. 18681, https://doi.org/10.1038/s41598-023-46003-4.